Fabrazyme Infusion

Agalsidase beta
35mg
GENZYME EUROPE B.V.
Pack size 1 Glass Vial (Powder)
Dispensing mode POM
Source NETHERLANDS
AgentGULF DRUG EST.
Retail Price 16853.50 AED

Available as:

Indications

Fabrazyme Infusion is used for: For treatment of Fabry's disease (alpha-galactosidase A deficiency)

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Agalsidase beta :

Mechanism of Action

Alpha-galactosidase A catalyzes the hydrolysis of globotriaosylceramide (GL-3) and other a-galactyl-terminated neutral glycosphingolipids, such as galabiosylceramide and blood group B substances to ceramide dihexoside and galactose.

Note

Fabrazyme 35mg Infusion manufactured by GENZYME EUROPE B.V.. Its generic name is Agalsidase beta. Fabrazyme is availble in United Arab Emirates. Farmaco UAE drug index information on Fabrazyme Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Agalsidase beta :